Tag: neurodegenerative diseases

March 17, 2017 Off

Pharnext starts Phase 3 trial for its neuro disease drug

By Dino Mustafić

Pharnext, a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, has enroled the first two patients to the international Phase 3 Extension Study PLEO-CMT-FU of PXT3003 at La Timone University Hospital (Marseille, France).